One of the best ways to ensure that a sponsor’s clinical and commercial programs reflect how patients experience a disease or a treatment is to …

In recent years, there has been an upsurge in the number of (bio) pharmaceutical products under development globally, reaching an estimated 7,471 products in 2021, …

Gene therapy and gene-mediated cell therapy (e.g. CAR-T cell therapy) approach hold great promise for treating debilitating diseases with unmet clinical needs. The drive to …

The shift toward decentralised trials (DCTs) was not caused by COVID-19 but has certainly been accelerated by it. Research indicates that just 28% of sponsors …

Within the clinical trials sector, there is an increasing demand for high-performing thermal packaging to meet the rising requirements of protecting pharma payloads, needing to …